{"id":"https://openalex.org/W2592571300","doi":"https://doi.org/10.1016/j.vph.2017.02.004","title":"Potential benefits of eicosapentaenoic acid on atherosclerotic plaques","display_name":"Potential benefits of eicosapentaenoic acid on atherosclerotic plaques","alternate_titles":[],"publication_year":2017,"publication_date":"2017-03-02","ids":{"openalex":"https://openalex.org/W2592571300","doi":"https://doi.org/10.1016/j.vph.2017.02.004","mag":"2592571300","pmid":"https://pubmed.ncbi.nlm.nih.gov/28263852"},"language":"en","primary_location":{"id":"doi:10.1016/j.vph.2017.02.004","doi":"https://doi.org/10.1016/j.vph.2017.02.004","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vph.2017.02.004","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1537189116303147/pdf","source":{"id":"https://openalex.org/S189127420","display_name":"Vascular Pharmacology","issn_l":"1537-1891","issn":["1537-1891","1879-3649"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vascular Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2592571300"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/pii/S1537189116303147/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077535835","display_name":"John R Nelson","orcid":"https://orcid.org/0000-0003-2455-0296","observed_orcids":["https://orcid.org/0000-0003-2455-0296"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"J.R. Nelson","raw_affiliation_strings":["California Cardiovascular Institute, 7061 N. Whitney, Suite 101, Fresno, CA 93720, United States. Electronic address: jr4nelson@yahoo.com","California Cardiovascular Institute, 7061 N. Whitney, Suite 101, Fresno, CA 93720, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"California Cardiovascular Institute, 7061 N. Whitney, Suite 101, Fresno, CA 93720, United States. Electronic address: jr4nelson@yahoo.com","institution_ids":[]},{"raw_affiliation_string":"California Cardiovascular Institute, 7061 N. Whitney, Suite 101, Fresno, CA 93720, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046688436","display_name":"Omar Rashid Wani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"O. Wani","raw_affiliation_strings":["Mountain Heart, 2000 South Thompson Street, Flagstaff, AZ 86001, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mountain Heart, 2000 South Thompson Street, Flagstaff, AZ 86001, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052549712","display_name":"Heidi Thomas May","orcid":"https://orcid.org/0000-0002-7524-5905","observed_orcids":["https://orcid.org/0000-0002-7524-5905"]},"institutions":[{"id":"https://openalex.org/I108785884","display_name":"Intermountain Healthcare","ror":"https://ror.org/04mvr1r74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I108785884"]},{"id":"https://openalex.org/I2803061204","display_name":"Intermountain Medical Center","ror":"https://ror.org/009c06z12","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I108785884","https://openalex.org/I2803061204"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H.T. May","raw_affiliation_strings":["Intermountain Heart Institute, 5121 South Cottonwood Street, Murray, UT 84157, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intermountain Heart Institute, 5121 South Cottonwood Street, Murray, UT 84157, United States","institution_ids":["https://openalex.org/I108785884","https://openalex.org/I2803061204"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079665496","display_name":"Matthew Jay Budoff","orcid":"https://orcid.org/0000-0002-9616-1946","observed_orcids":["https://orcid.org/0000-0002-9616-1946"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I177607063","display_name":"The Lundquist Institute","ror":"https://ror.org/025j2nd68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I177607063"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Budoff","raw_affiliation_strings":["Los Angeles Biomedical Research Institute at Harbor-UCLA, 1124 West Carson Street, Torrance, CA 90502, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Los Angeles Biomedical Research Institute at Harbor-UCLA, 1124 West Carson Street, Torrance, CA 90502, United States","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I177607063"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5077535835"],"corresponding_institution_ids":[],"apc_list":{"value":3670,"currency":"USD","value_usd":3670},"apc_paid":{"value":3670,"currency":"USD","value_usd":3670},"fwci":1.1084,"has_fulltext":true,"cited_by_count":92,"citation_normalized_percentile":{"value":0.77872671,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"91","issue":null,"first_page":"1","last_page":"9"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12955","display_name":"Atherosclerosis and Cardiovascular Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/eicosapentaenoic-acid","display_name":"eicosapentaenoic acid","score":1.0},{"id":"https://openalex.org/keywords/icosapent-ethyl","display_name":"icosapent ethyl","score":0.9100000262260437},{"id":"https://openalex.org/keywords/omega-3-fatty-acids","display_name":"omega-3 fatty acids","score":0.8610000014305115},{"id":"https://openalex.org/keywords/atherosclerotic-plaque","display_name":"atherosclerotic plaque","score":0.9539999961853027},{"id":"https://openalex.org/keywords/residual-cardiovascular-risk","display_name":"residual cardiovascular risk","score":0.9070000052452087},{"id":"https://openalex.org/keywords/statin-therapy","display_name":"statin therapy","score":0.8980000019073486},{"id":"https://openalex.org/keywords/unstable-plaque","display_name":"plaque vulnerability","score":0.6150000095367432},{"id":"https://openalex.org/keywords/plaque-progression","display_name":"plaque progression","score":0.7570000290870667},{"id":"https://openalex.org/keywords/pentraxin-3","display_name":"pentraxin 3","score":0.7699999809265137},{"id":"https://openalex.org/keywords/macrophage-accumulation","display_name":"macrophage accumulation","score":0.9850000143051147},{"id":"https://openalex.org/keywords/atherosclerotic-inflammation","display_name":"atherosclerotic inflammation","score":0.7870000004768372},{"id":"https://openalex.org/keywords/coronary-artery-disease","display_name":"coronary artery disease","score":0.7350000143051147},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.9800000190734863},{"id":"https://openalex.org/keywords/triglyceride-lowering","display_name":"triglyceride lowering","score":0.7940000295639038}],"concepts":[{"id":"https://openalex.org/C2776091944","wikidata":"https://www.wikidata.org/wiki/Q409990","display_name":"Eicosapentaenoic acid","level":4,"score":0.8955339193344116},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7312546372413635},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.5947935581207275},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.5601819157600403},{"id":"https://openalex.org/C2778213512","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Coronary artery disease","level":2,"score":0.5007326602935791},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4991922378540039},{"id":"https://openalex.org/C3017514745","wikidata":"https://www.wikidata.org/wiki/Q191756","display_name":"Omega 3 fatty acid","level":5,"score":0.45645448565483093},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39203155040740967},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.38884738087654114},{"id":"https://openalex.org/C19038510","wikidata":"https://www.wikidata.org/wiki/Q2005087","display_name":"Polyunsaturated fatty acid","level":3,"score":0.3515695333480835},{"id":"https://openalex.org/C543025807","wikidata":"https://www.wikidata.org/wiki/Q61476","display_name":"Fatty acid","level":2,"score":0.3379926085472107},{"id":"https://openalex.org/C2777171753","wikidata":"https://www.wikidata.org/wiki/Q423345","display_name":"Docosahexaenoic acid","level":4,"score":0.17428550124168396},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15132662653923035},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.10116523504257202}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001158","descriptor_name":"Arteries","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D001158","descriptor_name":"Arteries","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001158","descriptor_name":"Arteries","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001158","descriptor_name":"Arteries","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003952","descriptor_name":"Diagnostic Imaging","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015118","descriptor_name":"Eicosapentaenoic Acid","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015118","descriptor_name":"Eicosapentaenoic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D058226","descriptor_name":"Plaque, Atherosclerotic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.vph.2017.02.004","doi":"https://doi.org/10.1016/j.vph.2017.02.004","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vph.2017.02.004","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1537189116303147/pdf","source":{"id":"https://openalex.org/S189127420","display_name":"Vascular Pharmacology","issn_l":"1537-1891","issn":["1537-1891","1879-3649"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vascular Pharmacology","raw_type":"journal-article"},{"id":"pmid:28263852","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28263852","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vascular pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.vph.2017.02.004","doi":"https://doi.org/10.1016/j.vph.2017.02.004","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vph.2017.02.004","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1537189116303147/pdf","source":{"id":"https://openalex.org/S189127420","display_name":"Vascular Pharmacology","issn_l":"1537-1891","issn":["1537-1891","1879-3649"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vascular Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320315027","display_name":"Amarin Corporation","ror":"https://ror.org/02fccce66"},{"id":"https://openalex.org/F4320333619","display_name":"Amarin Pharma","ror":"https://ror.org/0353d6x38"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2592571300.pdf","grobid_xml":"https://content.openalex.org/works/W2592571300.grobid-xml"},"referenced_works_count":73,"referenced_works":["https://openalex.org/W20106442","https://openalex.org/W36187120","https://openalex.org/W182894011","https://openalex.org/W1554797744","https://openalex.org/W1853875009","https://openalex.org/W1921371649","https://openalex.org/W1970454392","https://openalex.org/W1981784337","https://openalex.org/W1984756098","https://openalex.org/W1985920370","https://openalex.org/W1987196137","https://openalex.org/W1991038212","https://openalex.org/W1995350891","https://openalex.org/W1997922075","https://openalex.org/W2007576400","https://openalex.org/W2009458118","https://openalex.org/W2010813622","https://openalex.org/W2020179495","https://openalex.org/W2021339583","https://openalex.org/W2023873454","https://openalex.org/W2025444929","https://openalex.org/W2032608025","https://openalex.org/W2037855075","https://openalex.org/W2048776656","https://openalex.org/W2049641685","https://openalex.org/W2051258508","https://openalex.org/W2057293475","https://openalex.org/W2071936488","https://openalex.org/W2074464351","https://openalex.org/W2082820286","https://openalex.org/W2090609282","https://openalex.org/W2091743718","https://openalex.org/W2093598997","https://openalex.org/W2097701710","https://openalex.org/W2099767767","https://openalex.org/W2106416671","https://openalex.org/W2107471253","https://openalex.org/W2107784628","https://openalex.org/W2110791515","https://openalex.org/W2115680750","https://openalex.org/W2130642206","https://openalex.org/W2131110587","https://openalex.org/W2132010550","https://openalex.org/W2132196134","https://openalex.org/W2138013532","https://openalex.org/W2142347023","https://openalex.org/W2144814726","https://openalex.org/W2145009492","https://openalex.org/W2151247869","https://openalex.org/W2151839802","https://openalex.org/W2156867452","https://openalex.org/W2161351985","https://openalex.org/W2163289440","https://openalex.org/W2169760772","https://openalex.org/W2171584145","https://openalex.org/W2216289267","https://openalex.org/W2236666692","https://openalex.org/W2252870030","https://openalex.org/W2290053204","https://openalex.org/W2296958313","https://openalex.org/W2314793531","https://openalex.org/W2330486239","https://openalex.org/W2330616215","https://openalex.org/W2335455113","https://openalex.org/W2341439667","https://openalex.org/W2344199980","https://openalex.org/W2345269362","https://openalex.org/W2347152603","https://openalex.org/W2472970460","https://openalex.org/W2509312821","https://openalex.org/W2527894800","https://openalex.org/W2551778421","https://openalex.org/W2598498016"],"related_works":["https://openalex.org/W1853875009","https://openalex.org/W2762372979","https://openalex.org/W2793850771","https://openalex.org/W4283588427","https://openalex.org/W3102461244","https://openalex.org/W2330616215","https://openalex.org/W3195392990","https://openalex.org/W3082332778","https://openalex.org/W4210567849","https://openalex.org/W3161583124"],"abstract_inverted_index":{"Residual":[0],"cardiovascular":[1],"(CV)":[2],"risk":[3,181],"remains":[4],"in":[5,119,124,134,178,182],"some":[6],"patients":[7,81,135,184],"despite":[8],"optimized":[9],"statin":[10,87,117,132,186],"therapy":[11,16,88],"and":[12,39,58,96,104,156],"may":[13,92],"necessitate":[14],"add-on":[15],"to":[17,152],"reduce":[18,153],"this":[19],"risk.":[20],"Eicosapentaenoic":[21],"acid":[22],"(EPA),":[23],"an":[24,163],"omega-3":[25],"polyunsaturated":[26],"fatty":[27],"acid,":[28],"lowers":[29],"plasma":[30],"triglyceride":[31,154],"levels":[32,38,54,155],"without":[33],"raising":[34],"low-density":[35],"lipoprotein":[36],"cholesterol":[37],"has":[40,72,149],"potential":[41,172],"beneficial":[42,74],"effects":[43,75],"on":[44,76],"atherosclerotic":[45,159],"plaques.":[46],"Animal":[47],"studies":[48],"have":[49],"shown":[50,73,151],"that":[51,90,113],"EPA":[52,71,91,100,114,146],"reduces":[53],"of":[55,67,80,145,158,162,175],"pro-inflammatory":[56],"cytokines":[57],"chemokines.":[59],"In":[60],"clinical":[61,173],"trials":[62],"utilizing":[63],"a":[64,116,120,131,141],"wide":[65],"spectrum":[66],"plaque":[68,77,94,98],"imaging":[69],"modalities,":[70],"characteristics.":[78],"Studies":[79],"with":[82,136],"coronary":[83,126],"artery":[84],"disease":[85],"receiving":[86,185],"suggest":[89],"decrease":[93],"vulnerability":[95],"prevent":[97],"progression.":[99],"also":[101],"decreased":[102],"pentraxin-3":[103],"macrophage":[105],"accumulation.":[106],"A":[107],"large,":[108],"randomized,":[109],"Japanese":[110],"study":[111,167],"reported":[112],"plus":[115],"resulted":[118],"19%":[121],"relative":[122],"reduction":[123],"major":[125],"events":[127],"at":[128],"5years":[129],"versus":[130],"alone":[133],"hypercholesterolemia":[137],"(P=0.011).":[138],"Icosapent":[139],"ethyl,":[140],"high-purity":[142],"prescription":[143],"form":[144],"ethyl":[147,177],"ester,":[148],"been":[150],"markers":[157],"inflammation.":[160],"Results":[161],"ongoing":[164],"CV":[165,180],"outcomes":[166],"will":[168],"further":[169],"define":[170],"the":[171],"benefits":[174],"icosapent":[176],"reducing":[179],"high-risk":[183],"therapy.":[187]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2592571300","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":21},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":6}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2017-03-16T00:00:00"}
